THE FOLLOW UP
STATEMENT

Merck will contribute 3.5 tons of ertapenem.

True

Evidence from credible sources supports the statement as accurate. Learn more in Methodology.

Interesting: 0/0 • Support: 0/0Log in to vote
funding

Contribution delivered as described.

Source summary
President Donald J. Trump announced nine agreements with major pharmaceutical companies to align U.S. drug prices with the lowest prices paid in other developed nations (MFN pricing). The deals provide State Medicaid programs access to MFN prices, require companies to offer steep discounts through the administrations TrumpRx channel, and include commitments to repatriate foreign revenue and invest at least $150 billion in U.S. manufacturing. Companies will also donate active pharmaceutical ingredients to a Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). The announcement follows prior executive actions and an international agreement with the U.K. to raise net prices there.
View original article →
Latest fact check

The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative involving nine major pharmaceutical companies to lower prescription drug prices and bolster national health security. Therefore, the statement that Merck will contribute 3.5 tons of ertapenem is accurate.

Sources

Timeline

  1. Update · Dec 21, 2025, 09:00 AMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative involving nine major pharmaceutical companies to lower prescription drug prices and bolster national health security. Therefore, the statement that Merck will contribute 3.5 tons of ertapenem is accurate.
  2. Update · Dec 21, 2025, 07:49 AMTrue
    The White House announced that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative where pharmaceutical manufacturers are donating active pharmaceutical ingredients to reduce reliance on foreign nations and ensure the United States has an adequate supply in the event of an emergency. (whitehouse.gov)
  3. Update · Dec 21, 2025, 07:04 AMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative where pharmaceutical manufacturers are collectively investing at least $150 billion in U.S. manufacturing and donating active pharmaceutical ingredients to SAPIR to reduce reliance on foreign nations and ensure the United States has an adequate supply of such products in the event of an emergency. (whitehouse.gov)
  4. Update · Dec 21, 2025, 05:55 AMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative involving nine major pharmaceutical companies to lower prescription drug prices and bolster national health security. The announcement specifies that Merck's donation is 3.5 tons of ertapenem.
  5. Update · Dec 21, 2025, 05:08 AMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative where pharmaceutical manufacturers are donating active pharmaceutical ingredients to reduce reliance on foreign nations and ensure the United States has an adequate supply in the event of an emergency. (whitehouse.gov)
  6. Update · Dec 21, 2025, 04:25 AMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative involving nine major pharmaceutical companies to lower prescription drug prices for Americans by aligning them with the lowest prices paid by other developed nations. (whitehouse.gov)
  7. Update · Dec 21, 2025, 02:56 AMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). This initiative is part of a broader effort to bolster national health security by reducing reliance on foreign nations and ensuring the United States has an adequate supply of essential medications in the event of an emergency. (whitehouse.gov)
  8. Update · Dec 20, 2025, 11:49 PMTrue
    The White House announced on December 19, 2025, that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative where several pharmaceutical companies are donating active pharmaceutical ingredients to SAPIR to reduce reliance on foreign nations and ensure the United States has an adequate supply of such products in the event of an emergency. (pharmasource.global)
  9. Update · Dec 20, 2025, 08:47 AMcomplete
    The White House announced that Merck will contribute 3.5 tons of ertapenem, an antibacterial medication used to treat complex infections, to the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). (whitehouse.gov) This contribution is part of a broader initiative where pharmaceutical manufacturers are donating active pharmaceutical ingredients to reduce reliance on foreign nations and ensure the United States has an adequate supply in the event of an emergency. (whitehouse.gov)
  10. Original article · Dec 19, 2025
    View article
Back to Countdowns

Comments

Only logged-in users can comment.
Loading…